| 000 | 01003 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250516083314.0 | ||
| 264 | 0 | _c20121018 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1742-7843 | ||
| 024 | 7 |
_a10.1111/j.1742-7843.2012.00878.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZamani, Nasim | |
| 245 | 0 | 0 |
_aIntravenous fat emulsion therapy: can it be tried without sufficient first-line treatment modalities? _h[electronic resource] |
| 260 |
_bBasic & clinical pharmacology & toxicology _cJul 2012 |
||
| 300 |
_a1-2; author reply 3 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aBupropion _xanalogs & derivatives |
| 650 | 0 | 4 | _aEating |
| 650 | 0 | 4 |
_aFat Emulsions, Intravenous _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tBasic & clinical pharmacology & toxicology _gvol. 111 _gno. 1 _gp. 1-2; author reply 3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1742-7843.2012.00878.x _zAvailable from publisher's website |
| 999 |
_c21634011 _d21634011 |
||